Response to "Re European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. MG. De Maeseneer et al. Eur J Vasc Endovasc Surg 2022;63:184-267."

We read with interest and commend the authors of the ESVS 2022 Chronic Venous Disease (CVD) clinical practice guidelines, 1 De Maeseneer M.G. Kakkos S.K. Aherne T. Baekgaard N. Black S. Blomgren L. et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022; 63: 184-267 Abstract Full Text Full Text PDF PubMed Scopus (98) Google Scholar but noted a few inconsistencies in section 3.3 (pharmacological treatment), which we would like to address. Response to “Re: European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. MG. De Maeseneer et al. Eur J Vasc Endovasc Surg 2022;63:184–267”European Journal of Vascular and Endovascular SurgeryVol. 64Issue 5PreviewWe would like to thank Paolini et al. for their letter regarding the recently published guidelines on the management of chronic venous disease (CVD).1 They claim they have found some inconsistencies in Section 3.3 on pharmacological treatment. Full-Text PDF